CHOC and UCI Health’s new designation is expected to attract more resources and recognition to help find novel cures for rare disorders.
CHOC’s After Cancer Treatment Survivorship program recognized with an award for collaboration
The ACTS program at the Hyundai Cancer Institute at CHOC receives recognition for their work to provide long-term care to cancer survivors.
Treating neonatal arteriovenous malformation with neurointerventional surgery
CHOC takes a multidisciplinary approach to detect AMV and treat it with life-saving neurointerventional surgery.
Precision 3D neuroimaging better pinpoints epileptogenic foci
CHOC is at the forefront of bringing precise, advanced 3D brain imaging to neurologists and their patients.
Senior scientist to retire after 26 years with Research Institute positioned for continued growth, success
Dr. Phil Schwartz loves to cook and create new therapies for kids with rare diseases. After 26 years at CHOC, he’s retiring.
Cryopreservation of ovarian tissue preserves fertility
CHOC participates in an ongoing innovative study on ovarian tissue transplantation that can help cancer patients have children in the future.
